Diabetes Conference-NFOD 2026

Safe pharmacological management is a cornerstone of effective diabetes care, but all antidiabetic agents carry potential adverse effects and risks. Monitoring for hypoglycemia, gastrointestinal disturbances, renal or hepatic effects, and drug interactions is essential to ensure patient safety. Clinicians must individualize therapy based on patient comorbidities, age, renal and hepatic function, and risk factors to minimize complications. Education on recognizing early warning signs, adherence to monitoring protocols, and timely adjustments to therapy are critical components of risk mitigation. By prioritizing drug safety and vigilance, healthcare providers can optimize treatment efficacy, prevent adverse events, and maintain high-quality, patient-centered diabetes care.